Tokyo Tape
Sign in
← Cuc

Annual report

9158.TEDINET S100W87M
Period2024-04-01 → 2025-03-31
Filed2025-06-27
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed
Key figures · 147
MetricValuePeriodScopeSource row
Revenue¥47.0bn2024-04-01 → 2025-03-31Cons.Revenue IFRS
Revenue¥33.0bn2023-04-01 → 2024-03-31Cons.Revenue IFRS
Revenue¥35.2bn2022-04-01 → 2023-03-31vCons.Revenue IFRS (5-year summary)
Revenue¥35.3bn2021-04-01 → 2022-03-31dCons.Revenue IFRS (5-year summary)
Revenue¥16.6bn2020-04-01 → 2021-03-31dCons.Revenue IFRS (5-year summary)
Operating income¥5.3bn2024-04-01 → 2025-03-31Cons.Operating profit loss IFRS
Operating income¥3.7bn2023-04-01 → 2024-03-31Cons.Operating profit loss IFRS
Profit before tax¥5.2bn2024-04-01 → 2025-03-31Cons.Profit loss before tax IFRS
Profit before tax¥4.1bn2023-04-01 → 2024-03-31Cons.Profit loss before tax IFRS
Profit before tax¥3.6bn2022-04-01 → 2023-03-31vCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥3.6bn2021-04-01 → 2022-03-31dCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥1.6bn2020-04-01 → 2021-03-31dCons.Profit loss before tax IFRS (5-year summary)
Net income (owners)¥3.1bn2024-04-01 → 2025-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥2.6bn2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥2.4bn2022-04-01 → 2023-03-31vCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥2.7bn2021-04-01 → 2022-03-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥1.1bn2020-04-01 → 2021-03-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income¥3.1bn2024-04-01 → 2025-03-31Cons.Profit loss IFRS
Net income¥2.6bn2023-04-01 → 2024-03-31Cons.Profit loss IFRS
Total assets¥85.2bnat 2025-03-31Cons.Assets IFRS
Total assets¥62.8bnat 2024-03-31Cons.Assets IFRS
Total assets¥39.8bnat 2023-03-31vCons.Total assets IFRS (5-year summary)
Total assets¥34.5bnat 2022-03-31dCons.Total assets IFRS (5-year summary)
Total assets¥28.4bnat 2021-03-31dCons.Total assets IFRS (5-year summary)
Total liabilities¥54.9bnat 2025-03-31Cons.Liabilities IFRS
Total liabilities¥34.8bnat 2024-03-31Cons.Liabilities IFRS
Net assets / equity¥30.3bnat 2025-03-31Cons.Equity IFRS
Net assets / equity¥28.0bnat 2024-03-31Cons.Equity IFRS
Net assets / equity¥11.9bnat 2023-03-31vCons.Equity IFRS
Equity (owners)¥29.7bnat 2025-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥27.3bnat 2024-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥11.7bnat 2023-03-31vCons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥9.5bnat 2022-03-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥4.7bnat 2021-03-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥7.5bnat 2025-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥8.3bnat 2024-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥4.1bnat 2023-03-31vCons.Cash and cash equivalents IFRS
Cash & equivalents¥4.4bnat 2022-03-31dCons.Cash and cash equivalents IFRS (5-year summary)
Cash & equivalents¥3.6bnat 2021-03-31dCons.Cash and cash equivalents IFRS (5-year summary)
Operating cash flow¥2.5bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥4.2bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥2.4bn2022-04-01 → 2023-03-31vCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥6.6bn2021-04-01 → 2022-03-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥2.1bn2020-04-01 → 2021-03-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Investing cash flow¥4.5bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥14.7bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥6.7bn2022-04-01 → 2023-03-31vCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥1.5bn2021-04-01 → 2022-03-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥2.4bn2020-04-01 → 2021-03-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Financing cash flow−¥7.6bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥14.4bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥4.0bn2022-04-01 → 2023-03-31vCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥4.4bn2021-04-01 → 2022-03-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥591m2020-04-01 → 2021-03-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
EPS (basic)¥106.812024-04-01 → 2025-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥93.992023-04-01 → 2024-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥113.92022-04-01 → 2023-03-31vCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥129.682021-04-01 → 2022-03-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥52.712020-04-01 → 2021-03-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (diluted)¥106.812024-04-01 → 2025-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥93.992023-04-01 → 2024-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥113.92022-04-01 → 2023-03-31vCons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥129.682021-04-01 → 2022-03-31dCons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥52.712020-04-01 → 2021-03-31dCons.Diluted earnings loss per share IFRS (5-year summary)
Net assets per share¥1,012.38at 2025-03-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥931.79at 2024-03-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥533.1at 2023-03-31vCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥453.12at 2022-03-31dCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥226.83at 2021-03-31dCons.Equity to asset ratio IFRS (5-year summary)
Equity ratio34.8%at 2025-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio43.5%at 2024-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio29.4%at 2023-03-31vCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio27.4%at 2022-03-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio16.6%at 2021-03-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
ROE11.0%2024-04-01 → 2025-03-31Cons.Rate of return on equity IFRS (5-year summary)
ROE13.3%2023-04-01 → 2024-03-31Cons.Rate of return on equity IFRS (5-year summary)
ROE22.9%2022-04-01 → 2023-03-31vCons.Rate of return on equity IFRS (5-year summary)
ROE38.1%2021-04-01 → 2022-03-31dCons.Rate of return on equity IFRS (5-year summary)
ROE27.1%2020-04-01 → 2021-03-31dCons.Rate of return on equity IFRS (5-year summary)
Employees5,145at 2025-03-31Cons.Number of employees
Employees3,743at 2024-03-31Cons.Number of employees
Employees2,994at 2023-03-31vCons.Number of employees
Employees2,470at 2022-03-31dCons.Number of employees
Employees1,819at 2021-03-31dCons.Number of employees
Revenue¥7.9bn2024-04-01 → 2025-03-31StandaloneNet sales
Revenue¥7.8bn2023-04-01 → 2024-03-31StandaloneNet sales
Revenue¥14.3bn2022-04-01 → 2023-03-31vStandaloneNet sales (5-year summary)
Revenue¥15.4bn2021-04-01 → 2022-03-31dStandaloneNet sales (5-year summary)
Revenue¥4.0bn2020-04-01 → 2021-03-31dStandaloneNet sales (5-year summary)
Operating income¥2.2bn2024-04-01 → 2025-03-31StandaloneOperating income
Operating income¥2.2bn2023-04-01 → 2024-03-31StandaloneOperating income
Ordinary income¥2.0bn2024-04-01 → 2025-03-31StandaloneOrdinary income
Ordinary income¥1.9bn2023-04-01 → 2024-03-31StandaloneOrdinary income
Ordinary income¥1.8bn2022-04-01 → 2023-03-31vStandaloneOrdinary income loss (5-year summary)
Ordinary income¥2.4bn2021-04-01 → 2022-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥795m2020-04-01 → 2021-03-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥2.1bn2024-04-01 → 2025-03-31StandaloneIncome before income taxes
Profit before tax¥1.9bn2023-04-01 → 2024-03-31StandaloneIncome before income taxes
Net income¥1.4bn2024-04-01 → 2025-03-31StandaloneProfit loss
Net income¥1.3bn2023-04-01 → 2024-03-31StandaloneProfit loss
Net income¥1.3bn2022-04-01 → 2023-03-31vStandaloneNet income loss (5-year summary)
Net income¥1.7bn2021-04-01 → 2022-03-31dStandaloneNet income loss (5-year summary)
Net income¥574m2020-04-01 → 2021-03-31dStandaloneNet income loss (5-year summary)
Total assets¥56.1bnat 2025-03-31StandaloneAssets
Total assets¥45.5bnat 2024-03-31StandaloneAssets
Total assets¥28.4bnat 2023-03-31vStandaloneTotal assets (5-year summary)
Total assets¥23.9bnat 2022-03-31dStandaloneTotal assets (5-year summary)
Total assets¥19.4bnat 2021-03-31dStandaloneTotal assets (5-year summary)
Total liabilities¥32.6bnat 2025-03-31StandaloneLiabilities
Total liabilities¥23.2bnat 2024-03-31StandaloneLiabilities
Net assets / equity¥23.5bnat 2025-03-31StandaloneNet assets
Net assets / equity¥22.3bnat 2024-03-31StandaloneNet assets
Net assets / equity¥8.1bnat 2023-03-31vStandaloneNet assets
Net assets / equity¥7.4bnat 2022-03-31dStandaloneNet assets (5-year summary)
Net assets / equity¥3.9bnat 2021-03-31dStandaloneNet assets (5-year summary)
Cash and deposits¥1.8bnat 2025-03-31StandaloneCash and deposits
Cash and deposits¥3.4bnat 2024-03-31StandaloneCash and deposits
EPS (basic)¥48.632024-04-01 → 2025-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥46.012023-04-01 → 2024-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥60.212022-04-01 → 2023-03-31vStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥78.532021-04-01 → 2022-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥25.982020-04-01 → 2021-03-31dStandaloneBasic earnings loss per share (5-year summary)
Net assets per share¥797.1at 2025-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥759.3at 2024-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥365.69at 2023-03-31vStandaloneNet assets per share (5-year summary)
Net assets per share¥335.57at 2022-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥176.49at 2021-03-31dStandaloneNet assets per share (5-year summary)
Equity ratio41.6%at 2025-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio48.8%at 2024-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio28.4%at 2023-03-31vStandaloneEquity to asset ratio (5-year summary)
Equity ratio30.9%at 2022-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio20.1%at 2021-03-31dStandaloneEquity to asset ratio (5-year summary)
ROE6.2%2024-04-01 → 2025-03-31StandaloneRate of return on equity (5-year summary)
ROE8.4%2023-04-01 → 2024-03-31StandaloneRate of return on equity (5-year summary)
ROE16.6%2022-04-01 → 2023-03-31vStandaloneRate of return on equity (5-year summary)
ROE30.6%2021-04-01 → 2022-03-31dStandaloneRate of return on equity (5-year summary)
ROE15.9%2020-04-01 → 2021-03-31dStandaloneRate of return on equity (5-year summary)
Shares issued29,990,400at 2025-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued29,990,400at 2024-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued113,152at 2023-03-31vStandaloneTotal number of issued shares (5-year summary)
Shares issued104,352at 2022-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued104,352at 2021-03-31dStandaloneTotal number of issued shares (5-year summary)
Employees467at 2025-03-31StandaloneNumber of employees
Employees434at 2024-03-31StandaloneNumber of employees
Employees423at 2023-03-31vStandaloneNumber of employees
Employees374at 2022-03-31dStandaloneNumber of employees
Employees304at 2021-03-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 60
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsemployeesat 2025-03-312 pure
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2024-04-01 → 2025-03-31¥120m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2024-04-01 → 2025-03-31¥120m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-04-01 → 2025-03-31¥55m
Reconciling Itemsreconcilingrevenue2024-04-01 → 2025-03-31−¥314m
Reconciling Itemsreconcilingrevenue intersegment2024-04-01 → 2025-03-31−¥314m
Reconciling Itemsreconcilingsegment profit2024-04-01 → 2025-03-31−¥834m
Hospicereportable segmentemployeesat 2025-03-311864 pure
Hospicereportable segmentrevenue2024-04-01 → 2025-03-31¥13.8bn
Hospicereportable segmentrevenue external2024-04-01 → 2025-03-31¥13.8bn
Hospicereportable segmentsegment profit2024-04-01 → 2025-03-31¥1.0bn
In Home Nursingreportable segmentemployeesat 2025-03-311591 pure
In Home Nursingreportable segmentrevenue2024-04-01 → 2025-03-31¥12.3bn
In Home Nursingreportable segmentrevenue external2024-04-01 → 2025-03-31¥12.3bn
In Home Nursingreportable segmentrevenue intersegment2024-04-01 → 2025-03-31¥0
In Home Nursingreportable segmentsegment profit2024-04-01 → 2025-03-31¥1.2bn
Medical Care Residencereportable segmentemployeesat 2025-03-31759 pure
Medical Care Residencereportable segmentrevenue2024-04-01 → 2025-03-31¥3.6bn
Medical Care Residencereportable segmentrevenue external2024-04-01 → 2025-03-31¥3.6bn
Medical Care Residencereportable segmentsegment profit2024-04-01 → 2025-03-31¥299m
Medical Institutionreportable segmentemployeesat 2025-03-31800 pure
Medical Institutionreportable segmentrevenue2024-04-01 → 2025-03-31¥17.6bn
Medical Institutionreportable segmentrevenue external2024-04-01 → 2025-03-31¥17.3bn
Medical Institutionreportable segmentrevenue intersegment2024-04-01 → 2025-03-31¥314m
Medical Institutionreportable segmentsegment profit2024-04-01 → 2025-03-31¥3.6bn
—segment totalrevenue2024-04-01 → 2025-03-31¥47.2bn
—segment totalrevenue external2024-04-01 → 2025-03-31¥46.9bn
—segment totalrevenue intersegment2024-04-01 → 2025-03-31¥314m
—segment totalsegment profit2024-04-01 → 2025-03-31¥6.1bn
Total Of Reportable Segments And Otherssegment totalrevenue2024-04-01 → 2025-03-31¥47.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-04-01 → 2025-03-31¥47.0bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2024-04-01 → 2025-03-31¥314m
Total Of Reportable Segments And Otherssegment totalsegment profit2024-04-01 → 2025-03-31¥6.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2024-03-31¥205m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-04-01 → 2024-03-31¥205m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2024-03-31¥18m
Reconciling Itemsreconcilingrevenue2023-04-01 → 2024-03-31−¥264m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2024-03-31−¥264m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2024-03-31−¥1.2bn
Hospicereportable segmentrevenue2023-04-01 → 2024-03-31¥10.4bn
Hospicereportable segmentrevenue external2023-04-01 → 2024-03-31¥10.4bn
Hospicereportable segmentrevenue intersegment2023-04-01 → 2024-03-31¥1m
Hospicereportable segmentsegment profit2023-04-01 → 2024-03-31¥405m
In Home Nursingreportable segmentrevenue2023-04-01 → 2024-03-31¥10.9bn
In Home Nursingreportable segmentrevenue external2023-04-01 → 2024-03-31¥10.9bn
In Home Nursingreportable segmentrevenue intersegment2023-04-01 → 2024-03-31¥0
In Home Nursingreportable segmentsegment profit2023-04-01 → 2024-03-31¥616m
Medical Institutionreportable segmentrevenue2023-04-01 → 2024-03-31¥11.8bn
Medical Institutionreportable segmentrevenue external2023-04-01 → 2024-03-31¥11.5bn
Medical Institutionreportable segmentrevenue intersegment2023-04-01 → 2024-03-31¥263m
Medical Institutionreportable segmentsegment profit2023-04-01 → 2024-03-31¥3.9bn
—segment totalrevenue2023-04-01 → 2024-03-31¥33.1bn
—segment totalrevenue external2023-04-01 → 2024-03-31¥32.8bn
—segment totalrevenue intersegment2023-04-01 → 2024-03-31¥264m
—segment totalsegment profit2023-04-01 → 2024-03-31¥4.9bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2024-03-31¥33.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2024-03-31¥33.0bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2024-03-31¥264m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2024-03-31¥4.9bn
Medical Institutionreportable segmentemployeesat 2025-03-31338 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,878
ItemContextValueUnit
Net assetsCurrentYearInstant_NonConsolidatedMember_ValuationDifferenceOnAvailableForSaleSecuritiesMember602000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_ValuationAndTranslationAdjustmentsMember602000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_SubscriptionRightsToSharesMember172000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember23539000000JPY
Personal expenses sgaPrior1YearDuration_NonConsolidatedMember1918000000JPY
Personal expenses sgaCurrentYearDuration_NonConsolidatedMember2141000000JPY
Business consignment expenses sgaPrior1YearDuration_NonConsolidatedMember473000000JPY
Business consignment expenses sgaCurrentYearDuration_NonConsolidatedMember442000000JPY
Commission fee sgaPrior1YearDuration_NonConsolidatedMember279000000JPY
Commission fee sgaCurrentYearDuration_NonConsolidatedMember427000000JPY
Compensations sgaPrior1YearDuration_NonConsolidatedMember104000000JPY
Compensations sgaCurrentYearDuration_NonConsolidatedMember93000000JPY
Taxes and dues sgaPrior1YearDuration_NonConsolidatedMember186000000JPY
Taxes and dues sgaCurrentYearDuration_NonConsolidatedMember167000000JPY
Recruiting expenses sgaPrior1YearDuration_NonConsolidatedMember215000000JPY
Recruiting expenses sgaCurrentYearDuration_NonConsolidatedMember156000000JPY
Traveling and transportation expenses sgaPrior1YearDuration_NonConsolidatedMember237000000JPY
Traveling and transportation expenses sgaCurrentYearDuration_NonConsolidatedMember269000000JPY
Rents sgaPrior1YearDuration_NonConsolidatedMember186000000JPY
Rents sgaCurrentYearDuration_NonConsolidatedMember183000000JPY
Depreciation sgaPrior1YearDuration_NonConsolidatedMember82000000JPY
Depreciation sgaCurrentYearDuration_NonConsolidatedMember87000000JPY
Supplies expenses sgaPrior1YearDuration_NonConsolidatedMember16000000JPY
Supplies expenses sgaCurrentYearDuration_NonConsolidatedMember28000000JPY
Training expenses sgaPrior1YearDuration_NonConsolidatedMember38000000JPY
Training expenses sgaCurrentYearDuration_NonConsolidatedMember33000000JPY
Communication expenses sgaPrior1YearDuration_NonConsolidatedMember35000000JPY
Communication expenses sgaCurrentYearDuration_NonConsolidatedMember31000000JPY
Entertainment expenses sgaPrior1YearDuration_NonConsolidatedMember49000000JPY
Entertainment expenses sgaCurrentYearDuration_NonConsolidatedMember53000000JPY
Share based compensation expenses sgaPrior1YearDuration_NonConsolidatedMember42000000JPY
Share based compensation expenses sgaCurrentYearDuration_NonConsolidatedMember136000000JPY
Other sgaPrior1YearDuration_NonConsolidatedMember152000000JPY
Other sgaCurrentYearDuration_NonConsolidatedMember166000000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)有価証券報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2025-06-27
Fiscal year cover pageFilingDateInstant
Original text (Japanese)第11期（自　2024年４月１日　至　2025年３月31日）
Company name cover pageFilingDateInstant
Original text (Japanese)株式会社シーユーシー
Company name in english cover pageFilingDateInstantCUC Inc.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役　　濵口　慶太
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都港区芝浦三丁目１番１号
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)03（5005）0808（代表）
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)経営企画本部　本部長　　大橋　悠介
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都港区芝浦三丁目１番１号
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)03（5005）0808（代表）
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)経営企画本部　本部長　　大橋　悠介
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE37214

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 21 of 21 passed
balance sheet identityconsolidated 2024-03-31pass
balance sheet identityconsolidated 2025-03-31pass
balance sheet identitynon_consolidated 2024-03-31pass rounding
balance sheet identitynon_consolidated 2025-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2023-03-31pass
statement vs summary · net assetsnon_consolidated 2024-03-31pass
statement vs summary · net assetsnon_consolidated 2025-03-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2024-03-31pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2025-03-31pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2024-03-31pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2025-03-31pass
statement vs summary · revenueconsolidated 2023-04-01/2024-03-31pass
statement vs summary · revenueconsolidated 2024-04-01/2025-03-31pass
statement vs summary · revenuenon_consolidated 2023-04-01/2024-03-31pass
statement vs summary · revenuenon_consolidated 2024-04-01/2025-03-31pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2025-03-31pass
statement vs summary · total assetsnon_consolidated 2024-03-31pass
statement vs summary · total assetsnon_consolidated 2025-03-31pass